12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks showed notable movements. BioSig Technologies, Coeptis Therapeutics, Alzamend Neuro, China Pharma Holding, AIM ImmunoTech, and Better Therapeutics were among the gainers, with increases ranging from 4.99% to 7.7%. On the downside, G1 Therapeutics, InVivo Therapeutics, 23andMe Holding, Calidi Biotherapeutics, Beyond Air, and Syra Health experienced declines between 6.61% and 37.5%. Notably, 23andMe's drop followed its Q3 earnings release three days prior, while Beyond Air's decline coincided with its Q3 earnings report.
February 12, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
G1 Therapeutics stock plummeted by 37.5% to $2.8, with a market cap of $145.1 million.
The drastic drop in G1 Therapeutics' stock price could indicate negative investor reaction to company-specific news or broader market conditions.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
23andMe Holding shares fell 10.64% to $0.69, with a market cap of $332.2 million, following its Q3 earnings release three days ago.
The decline in 23andMe's stock price post-Q3 earnings suggests the market's negative response to the earnings report or its contents.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 95
NEGATIVE IMPACT
Beyond Air shares decreased by 7.45% to $1.99, with a market cap of $70.8 million, coinciding with its Q3 earnings report.
The drop in Beyond Air's stock price on the day of its Q3 earnings report indicates a potentially negative market reaction to the earnings results.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 95
POSITIVE IMPACT
BioSig Technologies stock rose by 7.7% to $0.96, with a market cap of $8.9 million.
The significant after-market increase suggests positive investor sentiment, potentially due to company-specific news or broader market trends.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90